269 related articles for article (PubMed ID: 30301561)
1. Too many women are dying from cervix cancer: Problems and solutions.
Gaffney DK; Hashibe M; Kepka D; Maurer KA; Werner TL
Gynecol Oncol; 2018 Dec; 151(3):547-554. PubMed ID: 30301561
[TBL] [Abstract][Full Text] [Related]
2. Correlation between cervical carcinogenesis and tobacco use by sexual partners.
Siokos AG; Siokou-Siova O; Tzafetas I
Hell J Nucl Med; 2019; 22 Suppl 2():184-190. PubMed ID: 31802062
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of cancer of the cervix: global and national perspective.
Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K
J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
[TBL] [Abstract][Full Text] [Related]
4. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
5. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
[TBL] [Abstract][Full Text] [Related]
6. Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.
Rogel A; Belot A; Suzan F; Bossard N; Boussac M; Arveux P; Buémi A; Colonna M; Danzon A; Ganry O; Guizard AV; Grosclaude P; Velten M; Jougla E; Iwaz J; Estève J; Chérié-Challine L; Remontet L
Cancer Epidemiol; 2011 Jun; 35(3):243-9. PubMed ID: 21106450
[TBL] [Abstract][Full Text] [Related]
7. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.
Arbyn M; Weiderpass E; Bruni L; de Sanjosé S; Saraiya M; Ferlay J; Bray F
Lancet Glob Health; 2020 Feb; 8(2):e191-e203. PubMed ID: 31812369
[TBL] [Abstract][Full Text] [Related]
8. Mass screening in Sweden for cancer of the uterine cervix. Results and epidemiologic effect.
Kjellgren O
Acta Obstet Gynecol Scand Suppl; 1977; 67():5-11. PubMed ID: 269641
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide.
Mathew A; George PS
Asian Pac J Cancer Prev; 2009; 10(4):645-50. PubMed ID: 19827887
[TBL] [Abstract][Full Text] [Related]
10. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
11. [The accuracy of the causes of death and the estimated trend: the case of cervix uteri].
Mancuso P; Sacchettini C; Vicentini M; Caroli S; Giorgi Rossi P
Epidemiol Prev; 2016; 40(3-4):157-63. PubMed ID: 27436248
[TBL] [Abstract][Full Text] [Related]
12. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
13. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force.
Kim JJ; Burger EA; Regan C; Sy S
JAMA; 2018 Aug; 320(7):706-714. PubMed ID: 30140882
[TBL] [Abstract][Full Text] [Related]
14. Trends in cervical cancer incidence and mortality in Oklahoma and the United States, 1999-2013.
Gopalani SV; Janitz AE; Campbell JE
Cancer Epidemiol; 2018 Oct; 56():140-145. PubMed ID: 30176544
[TBL] [Abstract][Full Text] [Related]
15. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
16. Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer.
Luckett R; Feldman S
Hum Vaccin Immunother; 2016 Jun; 12(6):1332-42. PubMed ID: 26588179
[TBL] [Abstract][Full Text] [Related]
17. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.
; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Phipps MG; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2018 Aug; 320(7):674-686. PubMed ID: 30140884
[TBL] [Abstract][Full Text] [Related]
18. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
Kohl I
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
[TBL] [Abstract][Full Text] [Related]
19. [Audit of deaths due to cervical cancer in a health service of Santiago. A preliminary analysis].
Serra I; García V; Viñales D; Serra J; Serra L; Zamorano L; Decinti E
Rev Med Chil; 1998 Aug; 126(8):1010-8. PubMed ID: 9830755
[TBL] [Abstract][Full Text] [Related]
20. Global strategies for cervical cancer prevention.
Pimple S; Mishra G; Shastri S
Curr Opin Obstet Gynecol; 2016 Feb; 28(1):4-10. PubMed ID: 26642063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
